NCT05534633View on ClinicalTrials.gov

APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies

NAActive, not recruitingINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2025

Conditions
HIV InfectionsHCV InfectionSyphilis Infection
Interventions
OTHER

Choice of STBBI test(s)

Participants may receive a point of care HIV test, and/or point of care HCV test, and/or dry blood spot test, which can test for HIV, HCV, and syphilis, at the participants' choice.

Trial Locations (1)

A1A 0L1

Memorial University of Newfoundland, St. John's

All Listed Sponsors
lead

Memorial University of Newfoundland

OTHER